Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2012 October;103(5) > Minerva Medica 2012 October;103(5):343-51

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  MENOPAUSE: A CLOSER LOOK 

Minerva Medica 2012 October;103(5):343-51

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: English

Individualizing hormone-therapy according to cardiovascular risk

Shoupe D.

Reproductive Endocrinology and Infertility Obstetrics and Gynecology Keck School of Medicine at University of Southern California, Los Angeles, CA, USA


PDF


There is growing consensus that the benefit to risk profile for hormone therapy is high for healthy, low-risk women initiating therapy within 10 years of menopause or under age 60. However, special considerations are needed for women who are outside those boundaries or for those that have risk factors for cardiovascular disease.

top of page